Skip to content

In the BioHarmony Drug Report Database

Pilocarpine

Ocusert Pilo (pilocarpine) is a small molecule pharmaceutical. Pilocarpine was first approved as Ocusert Pilo on 1982-01-01. It is used to treat angle-closure glaucoma, head and neck neoplasms, mydriasis, and xerostomia in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M4, muscarinic acetylcholine receptor M5, muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M1, and cytochrome P450 2A6.
Trade Name Ocusert Pilo
Common Name Pilocarpine
Indication angle-closure glaucoma, head and neck neoplasms, mydriasis, xerostomia
Drug Class Tricyclic compounds
Pilocarpine
Get full access now